Overall rank by patents
#33,669
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Tremeau Pharmaceuticals, Inc.
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
8
Total patents granted
4
CPC technology areas
29.8
Avg claims per patent
-
5-year filing velocity
The verdict
Tremeau holds 8 US patents across 4 technology areas, rank #33,669 of 50,000 tracked assignees.
- #33,669
- of 50,000 US assignees by volume
- Top 35%
- by Innovation Score (40.8/100)
- 29.8
- avg claims per patent
Portfolio overview
Tremeau Pharmaceuticals, Inc. has been granted 8 US utility patents between 2021 and 2024, placing Tremeau Pharmaceuticals, Inc. at rank #33,669 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 29.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Tremeau Pharmaceuticals, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Tremeau sits between Transverse Medical, Inc. (8 patents, rank #33,665) and Tridonic Ag (8 patents, rank #33,673) - the closest US assignees by grant volume. The composite Innovation Score of 40.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Tremeau Pharmaceuticals, Inc.'s 29.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Tremeau Pharmaceuticals, Inc. against peers pursuing similar technology classes.
Who files at Tremeau's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Transverse Medical
Transverse Medical, Inc.
8 patents
- Travelpro Products
Travelpro Products, Inc.
8 patents
- Traxen
Traxen Inc.
8 patents
- Tredit Tire & Whe…
Tredit Tire & Wheel Company, Inc.
8 patents
- Triangle IP
Triangle IP, Inc.
8 patents
- Triangle Tyre
Triangle Tyre Co. Ltd.
8 patents
- Tricore
Tricore Corporation
8 patents
- Tridonic
Tridonic AG
8 patents
- Tremeau Pharmaceu… ◀
Tremeau Pharmaceuticals, Inc.
8 patents
What this shows Tremeau holds 8 patents at rank #33,669, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Tremeau
By rank, the assignees closest to #33,669 in granted patent volume.
- Transverse Medical, Inc. #33,665 · 8 patents
- Travelpro Products, Inc. #33,666 · 8 patents
- Traxen Inc. #33,667 · 8 patents
- Tredit Tire & Wheel Company, Inc. #33,668 · 8 patents
- Triangle IP, Inc. #33,670 · 8 patents
- Triangle Tyre Co. Ltd. #33,671 · 8 patents
- Tricore Corporation #33,672 · 8 patents
- Tridonic Ag #33,673 · 8 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Tremeau's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
Tremeau's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 3 | 37.5% |
| 2023 | 3 | 37.5% |
| 2024 | 2 | 25.0% |
Which technologies does Tremeau Pharmaceuticals, Inc. patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Frequently Asked Questions
How many patents does Tremeau Pharmaceuticals, Inc. hold?
Tremeau Pharmaceuticals, Inc. holds 8 US granted patents filed between 2021 and 2024, spanning 4 technology areas.
What is Tremeau Pharmaceuticals, Inc.'s Innovation Score?
Tremeau Pharmaceuticals, Inc. has an Innovation Score of 40.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Tremeau Pharmaceuticals, Inc. focus on?
Tremeau Pharmaceuticals, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 8 patents. The company has filed patents in 4 CPC subclasses total.
Is Tremeau Pharmaceuticals, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Tremeau Pharmaceuticals, Inc..
What does claim depth mean for Tremeau Pharmaceuticals, Inc.'s patents?
Tremeau Pharmaceuticals, Inc.'s patents average 29.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Tremeau Pharmaceuticals, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Tremeau's 8 grants land it in the top 35% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Tremeau ranks #33,669 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.